A Phase II, Single Arm Study of Chemoimmunotherapy for the Treatment of Men with Neuroendocrine or Aggressive Variant Metastatic Prostate Cancer (CHAMP)
Clinical Trial Grant
Awarded By
Bristol-Myers Squibb Company
Start Date
February 23, 2021
End Date
March 14, 2026
Awarded By
Bristol-Myers Squibb Company
Start Date
February 23, 2021
End Date
March 14, 2026